- GHK-Cu is the copper-binding tripeptide glycyl-L-histidyl-L-lysine copper(II) — molecular weight 340.4 Da (free peptide) or 403.9 Da (copper complex).
- Research focuses on copper-dependent metalloproteinase activity, collagen type I/III synthesis, MMP/TIMP modulation, and angiogenesis pathways.
- Cross-categorised in both Skin & Aesthetics and Tissue Repair & Regenerative categories at Advanced Peptide Science.
What is GHK-Cu?
GHK-Cu is the copper(II) complex of the naturally occurring tripeptide glycyl-L-histidyl-L-lysine (GHK). The free peptide has a molecular weight of 340.4 Da; the bioactive copper complex has a molecular weight of 403.9 Da and is supplied as the characteristic blue-green powder. The copper-binding chemistry is central to the compound’s biological activity — most research applications focus on the copper-bound form rather than the free tripeptide. Researchers can access GHK-Cu research peptide at Advanced Peptide Science at 99%+ HPLC-verified purity.
Research Background
The GHK tripeptide was originally isolated from human plasma in the 1970s, where it exists at physiological concentrations that decline with age. The copper-binding form (GHK-Cu) is the bioactive species investigated in regenerative and dermal research applications. The compound features prominently in pre-formulated research blends including the Glow Blend (with BPC-157 and TB-500) and the KLOW Blend (with KPV, BPC-157, and TB-500). The cross-categorisation in both Skin & Aesthetics and Tissue Repair & Regenerative categories reflects research applications spanning dermal biology and broader regenerative pathways.
Mechanism of Action
GHK-Cu mechanism research focuses on copper-dependent enzymatic modulation. The compound modulates the balance between matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) — a fundamental regulatory system controlling extracellular matrix turnover. Research investigates upregulation of collagen type I and type III synthesis in fibroblasts, supporting dermal extracellular matrix accumulation. Additional research focuses on antioxidant pathway activation via copper-dependent enzymatic activity, angiogenesis induction supporting tissue revascularisation, and gene expression effects on collagen, MMP, and TIMP regulatory loci.
Key Research Findings
Collagen Synthesis Stimulation
GHK-Cu research investigates stimulation of collagen type I/III synthesis in fibroblasts. The dermal extracellular matrix is approximately 80% type I collagen, so type I synthesis stimulation has implications for dermal research applications. Type III collagen is more abundant in young skin and at wound-healing sites — making the combined type I/III synthesis profile relevant to both maintenance and repair research lineages.
MMP/TIMP Balance Modulation
Matrix metalloproteinases (MMPs) degrade extracellular matrix components; tissue inhibitors of metalloproteinases (TIMPs) inhibit MMP activity. The balance between MMP and TIMP activity determines net matrix turnover. GHK-Cu research investigates modulation of this balance — shifting toward conditions favouring matrix accumulation rather than degradation.
Antioxidant Pathway Activation
The copper-binding chemistry of GHK-Cu enables interaction with copper-dependent antioxidant enzymes including superoxide dismutase (SOD1). Research investigates effects on cellular oxidative stress responses and downstream antioxidant gene expression patterns.
Research Applications
GHK-Cu research applications span dermal extracellular matrix research, copper-dependent enzyme pharmacology, collagen synthesis pathway investigation, and multi-compound regenerative research via the Glow Blend and KLOW Blend formulations. Comparative research against non-copper-binding tripeptides isolates the contribution of copper chemistry to the observed biological effects — a fundamental research-tool framework for understanding metal-binding peptide pharmacology.
Research Specifications
| Molecular Weight | 340.4 Da (free peptide) / 403.9 Da (copper complex) |
| Sequence | Glycyl-L-histidyl-L-lysine (GHK) + copper(II) |
| Appearance | Blue-green powder (copper complex form) |
| Primary Mechanism | Copper-dependent MMP/TIMP modulation + collagen synthesis stimulation |
| Format | Lyophilized powder in sterile vial |
| Purity | ≥ 99% (HPLC verified) |
| Storage | -20 °C, protect from light |
Frequently Asked Questions
Why is GHK-Cu blue-green?
The blue-green colour reflects the copper(II) complex of the GHK tripeptide. Copper(II) complexes characteristically absorb light in the red-orange range, transmitting blue-green wavelengths. The colour confirms the copper-bound bioactive form.
Is GHK-Cu in any pre-formulated blends?
Yes. GHK-Cu is a component of the Glow Blend (with BPC-157 and TB-500) and the four-compound KLOW Blend (with BPC-157, TB-500, and KPV).
What is the molecular weight difference between free GHK and the copper complex?
Free GHK is 340.4 Da; the copper(II) complex is 403.9 Da. The 63.5 Da difference reflects the copper(II) atom plus minor charge adjustments. The bioactive form is the copper complex.
Is GHK-Cu approved for human use?
Advanced Peptide Science supplies GHK-Cu exclusively for in vitro and in vivo scientific research. Not for human consumption. Research use only.
For Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
